Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
3.410
-0.120 (-3.40%)
At close: Oct 5, 2026, 4:00 PM EDT
3.450
+0.040 (1.17%)
After-hours: Oct 5, 2026, 7:56 PM EDT
Lexeo Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
63
Market Cap
279.76M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 654.00K | -1.00M | -60.53% |
| Dec 31, 2021 | 1.66M | 1.14M | 219.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vanda Pharmaceuticals | 215.72M |
| Century Therapeutics | 109.16M |
| Fulcrum Therapeutics | 80.00M |
| Clinuvel Pharmaceuticals | 65.05M |
| Abeona Therapeutics | 25.52M |
| X4 Pharmaceuticals | 15.85M |
| Fate Therapeutics | 6.49M |
| Upstream Bio | 3.16M |
LXEO News
- 4 days ago - Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson's Disease and Movement Disorders 2026 (MDS) - GlobeNewsWire
- 5 days ago - Lexeo Therapeutics Transcript: Stifel 2026 Virtual Cardiometabolic Forum - Transcripts
- 12 days ago - Apertura Gene Therapy to Provide Lexeo Therapeutics Access to TfR1 CapX™ for Program Designed to Treat Friedreich Ataxia - PRNewsWire
- 12 days ago - Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum - GlobeNewsWire
- 13 days ago - Lexeo Therapeutics Transcript: M&A announcement - Transcripts
- 13 days ago - Lexeo Therapeutics Press release: M&A announcement - Filings
- 13 days ago - Lexeo Therapeutics Slides: M&A announcement - Filings
- 13 days ago - Lexeo Therapeutics enter into agreement to acquire Mantle Therapeutics - TheFly